Bio-Techne (TECH) FCF Payout Ratio Growth (1y) (2010 - 2026)
Bio-Techne (TECH) FCF Payout Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Bio-Techne |
9.04 Bn |
8.83 Bn |
208.29 Mn |
-60.24% |
| Date | Value |
|---|
| Mar 31, 2026 |
-60.24% |
| Dec 31, 2025 |
-0.76% |
| Sep 30, 2025 |
141.49% |
| Jun 30, 2025 |
-39.53% |
| Mar 31, 2025 |
108.25% |
| Dec 31, 2024 |
-10.72% |
| Sep 30, 2024 |
-16.09% |
| Jun 30, 2024 |
26.46% |
| Mar 31, 2024 |
-39.92% |
| Dec 31, 2023 |
-14.63% |
| Sep 30, 2023 |
2.49% |
| Jun 30, 2023 |
23.42% |
| Mar 31, 2023 |
49.67% |
| Dec 31, 2022 |
55.67% |
| Sep 30, 2022 |
-8.56% |
| Jun 30, 2022 |
25.09% |
| Mar 31, 2022 |
11.91% |
| Dec 31, 2021 |
-13.04% |
| Sep 30, 2021 |
31.65% |
| Jun 30, 2021 |
-74.85% |
